These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 23276824)
1. Prospective study of urinary and serum cross-linked N-telopeptide of type I collagen (NTx) for diagnosis of bone metastasis in patients with lung cancer. Tamiya M; Tokunaga S; Okada H; Suzuki H; Kobayashi M; Sasada S; Okamoto N; Morishita N; Matsuura Y; Miyamoto N; Hattori M; Taira K; Daga H; Takeda K; Hirashima T Clin Lung Cancer; 2013 Jul; 14(4):364-9. PubMed ID: 23276824 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Bone Metastasis Using Serial Measurements of Serum N-Telopeptides of Type I Collagen in Patients with Lung Cancer: A Prospective Study. Tamiya M; Tokunaga S; Okada H; Suzuki H; Sasada S; Okamoto N; Morishita N; Shiroyama T; Otsuka T; Miyamoto N; Taira K; Daga H; Takeda K; Hirashima T Anticancer Res; 2015 Jul; 35(7):3987-93. PubMed ID: 26124346 [TBL] [Abstract][Full Text] [Related]
3. Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancer. Tamiya M; Kobayashi M; Morimura O; Yasue T; Nakasuji T; Satomu M; Kohei O; Takayuki S; Morishita N; Suzuki H; Sasada S; Okamoto N; Hirashima T; Kawase I Clin Lung Cancer; 2013 Jan; 14(1):50-4. PubMed ID: 22609050 [TBL] [Abstract][Full Text] [Related]
4. Serum N-telopeptide of type I collagen and bone alkaline phosphatase and their relationship in patients with non-small cell lung carcinoma and bone metastases. Preliminary results. Lumachi F; Marino F; Fanti G; Chiara GB; Basso SM Anticancer Res; 2011 Nov; 31(11):3879-81. PubMed ID: 22110213 [TBL] [Abstract][Full Text] [Related]
5. Correlation of urine type I collagen-cross-linked N telopeptide levels with bone scintigraphic results in prostate cancer patients. Fukumitsu N; Uchiyama M; Mori Y; Yanada S; Hatano T; Igarashi H; Kishimoto K; Nakada J; Yoshihiro A; Harada J Metabolism; 2002 Jul; 51(7):814-8. PubMed ID: 12077723 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer. Tamiya M; Suzuki H; Kobayashi M; Sasada S; Okamoto N; Morishita N; Yasue T; Matsuura Y; Hirashima T; Kawase I Med Oncol; 2012 Mar; 29(1):215-8. PubMed ID: 21258879 [TBL] [Abstract][Full Text] [Related]
7. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss]. Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543 [TBL] [Abstract][Full Text] [Related]
8. Elevated N-telopeptide as a potential diagnostic marker for bone metastasis in lung cancer: A meta-analysis. Liu B; Zhao Y; Yuan J; Zeng L; Sun R; Meng X; Yang S PLoS One; 2017; 12(11):e0187860. PubMed ID: 29182642 [TBL] [Abstract][Full Text] [Related]
9. Preoperative serum pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen level predicts postoperative distant metastasis in patients with non-small-cell lung cancer. Tanaka Y; Yoshimasu T; Oura S; Hirai Y; Kawago M; Ikeda M; Okamura Y Eur J Cardiothorac Surg; 2013 Sep; 44(3):539-43; discussion 543. PubMed ID: 23435520 [TBL] [Abstract][Full Text] [Related]
10. Type I collagen metabolites as tumor markers in patients with lung carcinoma. Kobayashi T; Gabazza EC; Taguchi O; Risteli J; Risteli L; Kobayashi H; Yasui H; Yuda H; Sakai T; Kaneda M; Adachi Y Cancer; 1999 May; 85(9):1951-7. PubMed ID: 10223235 [TBL] [Abstract][Full Text] [Related]
11. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis. Koizumi M; Takahashi S; Ogata E Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607 [TBL] [Abstract][Full Text] [Related]
12. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer. Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma. Izumi M; Nakanishi Y; Takayama K; Kimotsuki K; Inoue K; Wataya H; Minami T; Hara N Cancer; 2001 Apr; 91(8):1487-93. PubMed ID: 11301396 [TBL] [Abstract][Full Text] [Related]
14. Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates. Fizazi K; Lipton A; Mariette X; Body JJ; Rahim Y; Gralow JR; Gao G; Wu L; Sohn W; Jun S J Clin Oncol; 2009 Apr; 27(10):1564-71. PubMed ID: 19237632 [TBL] [Abstract][Full Text] [Related]
15. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures. Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373 [TBL] [Abstract][Full Text] [Related]
16. [Comparative study of bone resorption markers for the diagnosis of bone metastasis in lung cancer]. Nakamura H; Oishi S; Yagyu H; Morisako T; Kishi K; Tsuchida F; Adachi H; Sarashina G; Sudoh A; Hashimoto T; Matsuoka T Nihon Kokyuki Gakkai Zasshi; 2002 May; 40(5):355-9. PubMed ID: 12166253 [TBL] [Abstract][Full Text] [Related]
17. Determination and biological relevance of serum cross-linked type I collagen N-telopeptide and bone-specific alkaline phosphatase in breast metastatic cancer. Kanakis I; Nikolaou M; Pectasides D; Kiamouris C; Karamanos NK J Pharm Biomed Anal; 2004 Mar; 34(4):827-32. PubMed ID: 15019061 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer. Pectasides D; Farmakis D; Nikolaou M; Kanakis I; Kostopoulou V; Papaconstantinou I; Karamanos NK; Economopoulos T; Raptis SA J Pharm Biomed Anal; 2005 Feb; 37(1):171-6. PubMed ID: 15664758 [TBL] [Abstract][Full Text] [Related]
19. Usefulness of bone metabolic markers in the diagnosis of bone metastasis from lung cancer. Chung JH; Park MS; Kim YS; Chang J; Kim JH; Kim SK; Kim SK Yonsei Med J; 2005 Jun; 46(3):388-93. PubMed ID: 15988811 [TBL] [Abstract][Full Text] [Related]
20. [Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) for diagnosis of bone metastasis in patients with primary lung cancer]. Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M Nihon Kokyuki Gakkai Zasshi; 2003 Dec; 41(12):857-60. PubMed ID: 14727545 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]